Testing effectiveness (Phase 2)Looking for participantsNCT07606365What this trial is testingA Study in Adults With Geographic AtrophyWho this might be right forGeographic Atrophy Sitala Bio LTD 300
Not applicableActive Not RecruitingNCT06345664What this trial is testingInterdisciplinary E-health Based Follow-up of Preterm Born ChildrenWho this might be right forPreterm Birth University Hospital Tuebingen 90
Not applicableStudy completedNCT04910399What this trial is testingDevelopment of an Innovative Health Ingredient From Marine By-products for the Healthy AgingWho this might be right forMemory ImpairmentAge-related Cognitive Decline Abyss Ingredients 53
Not applicableStudy completedNCT01790802What this trial is testingLaser Intervention in Early Age-Related Macular Degeneration StudyWho this might be right forAge-related Macular Degeneration Center for Eye Research Australia 292
Large-scale testing (Phase 3)Study completedNCT02462928What this trial is testingA Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular DegenerationWho this might be right forMacular Degeneration Allergan 939
Not applicableStudy completedNCT04778436What this trial is testingMacula Evolution in Patients With AMD Taking Oral Food SupplementationWho this might be right forAge Related Macular Degeneration Laboratoires Thea 10
Not applicableNot Yet RecruitingNCT04875234What this trial is testingVision Improvement for Legally Blind Dry AMD PatientsWho this might be right forDry Age-related Macular DegenerationVision Impairment and Blindness Optimal Acuity Corporation 40
Not applicableStudy completedNCT03903965What this trial is testingComparison of Retinal Perfusion Between Diabetic and Non-diabetic Patients With OCT Angiography After Cataract Surgery.Who this might be right forDiabetes Mellitus Type 2Age Related Cataracts Peking University Third Hospital 120
Not applicableStudy completedNCT02174211What this trial is testingA Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy.Who this might be right forAge Related Macular Degeneration King's College Hospital NHS Trust 59
Testing effectiveness (Phase 2)Study completedNCT01344993What this trial is testingSafety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular DegenerationWho this might be right forDry Age Related Macular Degeneration Astellas Institute for Regenerative Medicine 13
Testing effectiveness (Phase 2)Looking for participantsNCT07205887What this trial is testingA Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVOWho this might be right forNeovascular Age-Related Macular Degeneration (NVAMD)Branch Retinal Vein Occlusion (BRVO) EyeBiotech Ltd. 160
Post-approval studies (Phase 4)Study completedNCT00805649What this trial is testingCombined Therapy in Age-Related Macular Degeneration (ARMD)Who this might be right forAge-Related Macular Degeneration Johann Wolfgang Goethe University Hospital 150
Not applicableStudy completedNCT02572999What this trial is testingIncidence and Risk Factors for Hospitalization-Associated DisabilityWho this might be right forFunctional DeclineHospitalization-associated DisabilityIatrogenic Disease Universitaire Ziekenhuizen KU Leuven 80
Early research (Phase 1)WithdrawnNCT00538538What this trial is testingSubretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD)Who this might be right forRetinal HemorrhageMacular Degeneration Corewell Health East
Early research (Phase 1)Study completedNCT03748784What this trial is testingADVM-022 Intravitreal Gene Therapy for Wet AMDWho this might be right forWet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration Adverum Biotechnologies, Inc. 30
Large-scale testing (Phase 3)Looking for participantsNCT06635148What this trial is testingA Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)Who this might be right forGeographic AtrophyMacular Degeneration Janssen Research & Development, LLC 274
Not applicableStudy completedNCT02941263What this trial is testingNatural History of Geographic Atrophy Associated With Age-Related Macular DegenerationWho this might be right forAge-Related Macular Degeneration National Eye Institute (NEI) 20
Not applicableStudy completedNCT02291887What this trial is testingGenetic Analysis of Patients Responsive to Ranibizumab But Resistant to AfliberceptWho this might be right forAge-Related Macular Degeneration Associated Retinal Consultants, Michigan 13
Post-approval studies (Phase 4)Study completedNCT01831947What this trial is testingEfficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.Who this might be right forMacular Degeneration Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 40
Early research (Phase 1)Study completedNCT00473928What this trial is testingSafety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)Who this might be right forAge-Related Macular Degeneration Potentia Pharmaceuticals, Inc. 27